Order on the 2021 DRG system published in France

07

Apr 2021

On March 31, 2021, the Order of the Ministry of Solidarity and Health on the 2021 DRG system was published in the Official Journal of the French Republic. The Order includes information on the recent updates of the DRG system, DRG tariffs, supplements for private and public hospitals, as well as the tariffs for specific packages (emergency treatment package, ATU; small equipment package, FFM; safety and hospital environment package, SE; administration package for pharmaceutical products, services, and specialties in a hospital environment, APE) applicable to the procedures performed in a hospital environment but without hospitalization, etc.

The DRG tariffs were, in general, increased. The main changes are related to the financing of the emergency care performed in short-term hospitalization units (UHCD). Except for this, two new "safety and hospital environment" (SE) packages were created for botulinum toxin procedures (administration of botulinum toxin to the eyelids and administration of botulinum toxin to striated muscles). Pancreatic islet transplantation will now be reimbursed via DRG because Clinical Research Hospital Program (PHRC) concerning this procedure was finished.

The full details in French can be found here.

This news is just one of about 300 market access news collected by our team in the subscription services "HTA Alerts" and "Reimbursement Alerts" every two weeks from more than 80 organizations. Access our paid subscription services to stay on top of all developments specifically for your products in Europe (reimbursement news) and globally (HTA news). First EU issues of both newsletters are available for download free-of-charge.

Not ready for a subscription service? Subscribe to our free-of-charge newsletter delivered every second week to get updates about key reimbursement developments in Europe (10-12 news every two weeks).

The latest related news

18

Mar 2022

On February 22, 2022, a repository of innovative acts outside the nomenclature of biology and anatomopathology (RIHN) and a Supplementary list of IVD tests were published. Minor changes were introduced in the 2022 RIHN list.

Read more

14

Mar 2022

In February 2021, the Clinical Coding and Schedule Development (CCSD) working group, which develops and maintains procedural and diagnostics nomenclature for private payers in England, published Bulletins 0182 and 0079 with changes to be implemented no later than April 10, 2022. Three new procedure codes concerned robotic surgery in orthopaedic area, spinal procedures, and ophthalmology, and five new diagnostic codes were introduced.

Read more

08

Mar 2022

At the end of February 2022, the Dental and Pharmaceutical Benefits Agency (TLV) has launched a theme survey on products for monitoring and diagnostics of sepsis to identify products that may be relevant for health economic assessments at TLV. The suggestions for the products of interest, ongoing clinical studies, or innovation projects could be received until 23 March 2022.

Read more

07

Mar 2022

On February 08, 2022, the Reimbursement Commission of the Social Security Institution released an updated version of the Healthcare Implementation Communique. The main changes relate to the increase in reimbursement fees of services and medical devices by approximately 35-75%.

Read more

03

Mar 2022

In February 2022, two more health apps were introduced in the Directory of digital health applications (DiGAs) at the Federal Office for Drugs and Medical Devices (BfArM) and thus became reimbursable. These apps can be prescribed by physicians and psychotherapists and will be reimbursed by health insurers. In total, thirty health apps are now available at the DiGA Directory.

Read more